NOVOCURE LTD
NASDAQ: NVCR (NovoCure Limited)
Last update: 2 days ago, 5:05PM21.99
-0.18 (-0.81%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bullish | Bearish |
| Medical Devices (Global) | Bullish | Bearish | |
| Stock | NovoCure Limited | Bullish | Bearish |
Analyst Consensus
2 Buy, 3 Hold
Avg. Price @ Call: 14.42
|
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| 52 Weeks Range |
10.87 - 83.47
|
|
| Price Target Range | ||
| High | 42.00 (Wells Fargo, 91.00%) | Buy |
| Median | 22.00 (0.05%) | |
| Low | 15.00 (Evercore ISI Group, -31.79%) | Hold |
| Average | 24.80 (12.78%) | |
| Total | 2 Buy, 3 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 02 May 2024 | 22.00 (0.05%) | Hold | 14.19 |
| 27 Mar 2024 | 24.00 (9.14%) | Hold | 14.64 | |
| Piper Sandler | 10 Apr 2024 | 28.00 (27.33%) | Buy | 14.62 |
| Wells Fargo | 03 Apr 2024 | 42.00 (91.00%) | Buy | 14.42 |
| JP Morgan | 20 Mar 2024 | 17.00 (-22.69%) | Hold | 13.63 |
| 19 Mar 2024 | 17.00 (-22.69%) | Hold | 13.54 | |
| Evercore ISI Group | 23 Feb 2024 | 15.00 (-31.79%) | Hold | 15.22 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |